Abstract

Although many genes have been identified using high throughput technologies in endometriosis (ES), only a small number of individual genes have been analyzed functionally. This is due to the complexity of the disease that has different stages and is affected by various genetic and environmental factors. Many genes are upregulated or downregulated at each stage of the disease, thus making it difficult to identify key genes. In addition, little is known about the differences between the different stages of the disease. We assumed that the study of the identified genes in ES at a system-level can help to better understand the molecular mechanism of the disease at different stages of the development. We used publicly available microarray data containing archived endometrial samples from women with minimal/mild endometriosis (MMES), mild/severe endometriosis (MSES) and without endometriosis. Using weighted gene co-expression analysis (WGCNA), functional modules were derived from normal endometrium (NEM) as the reference sample. Subsequently, we tested whether the topology or connectivity pattern of the modules was preserved in MMES and/or MSES. Common and specific hub genes were identified in non-preserved modules. Accordingly, hub genes were detected in the non-preserved modules at each stage. We identified sixteen co-expression modules. Of the 16 modules, nine were non-preserved in both MMES and MSES whereas five were preserved in NEM, MMES, and MSES. Importantly, two non-preserved modules were found in either MMES or MSES, highlighting differences between the two stages of the disease. Analyzing the hub genes in the non-preserved modules showed that they mostly lost or gained their centrality in NEM after developing the disease into MMES and MSES. The same scenario was observed, when the severeness of the disease switched from MMES to MSES. Interestingly, the expression analysis of the new selected gene candidates including CC2D2A, AEBP1, HOXB6, IER3, and STX18 as well as IGF-1, CYP11A1 and MMP-2 could validate such shifts between different stages. The overrepresented gene ontology (GO) terms were enriched in specific modules, such as genetic disposition, estrogen dependence, progesterone resistance and inflammation, which are known as endometriosis hallmarks. Some modules uncovered novel co-expressed gene clusters that were not previously discovered.

Highlights

  • IntroductionA cycle of changes occurs in both the uterus and ovary. During this cycle, the cyclical changes in normal endometrium (NEM) are divided into three phases: (i) menstrual phase, (ii) proliferative phase, and (iii) secretory phase

  • During the menstrual cycle, a cycle of changes occurs in both the uterus and ovary

  • We aimed to answer a number of questions: (1) what are significant modules at different stages of ES? (2) which genes tend to be hubs in significant modules? (3) what are common hub genes in normal endometrium (NEM) and ES? (4) what are specific hub genes in NEM and ES? (5) which significant modules are topologically preserved at each stage of the disease? (6) which gene ontology (GO) terms are enriched in each module? and (7) which of the previously identified genes are rediscovered as hubs in the modules, and where are they in the network?

Read more

Summary

Introduction

A cycle of changes occurs in both the uterus and ovary. During this cycle, the cyclical changes in normal endometrium (NEM) are divided into three phases: (i) menstrual phase, (ii) proliferative phase, and (iii) secretory phase. Endometrial glandular and stromal tissues grow inside the uterus but in some condition, they grow outside the uterus, which is known as the endometriosis (ES) disease. This extrauterine growth (ectopic endometrium) induces a chronic, inflammatory reaction. ES is diagnosed and staged into four classes based on the level of severity and progression of the disease: stage I (minimal), stage II (mild), stage III (moderate), and stage IV (severe). On average, it takes about 11 years from symptom onset to diagnosis. This is mainly due to the complexity of the disease, which makes it difficult for researchers to study its underlying molecular mechanism

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call